Who is Visby Medical?

Watch our video to learn more about our mission and story.

Our Journey

Our story begins in 2010, when the earliest team members began to explore the idea of a diagnostic test that could be used by anyone, anywhere.

The concept

2010 - 2011

While completing an Entrepreneur-in-Residence at Artiman Ventures, Visby founder Adam de la Zerda explores the concept of a diagnostic so simple it could be used by anyone, anywhere.

Company founded

2012

After researching the market and finding nothing significant, Adam incorporates Click Diagnostics in December. Soon after, Greg Loney joins as a founding executive and the VP of engineering.

Focusing on sexual health

2013

Click Diagnostics explores a number of markets and identifies sexual health as the direction to pursue. Work begins on an STI test focused on women’s health.

First functional prototype

2017

Visby develops its first fully integrated device. Small enough to fit in the palm of your hand, the PCR test delivers rapid and accurate results.

FDA clinical study

2019

NIH sponsors the FDA clinical study for the sexual health product.

Sexual Health Test - FDA submission

2020

Click Diagnostics submits its package to the FDA for its sexual health test. By mid-March, the team decides to join the fight against a new SARS pathogen, COVID-19.

Name change

2020

In March, Click Diagnostics officially becomes Visby Medical.

Visby Medical COVID-19 Test

2020

By July, Visby Medical has a functional COVID-19 test. It receives its first authorization from the FDA in September.

Meet Our Team

We’re all about connecting the dots. From problem-solving to discovering new solutions, we pride ourselves on assembling a team that values curiosity, determination, and creative, empathic thinking.

Visby Leadership